ProfileGDS5822 / ILMN_2750493
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 51% 5% 18% 28% 13% 36% 30% 57% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.551
GSM1276600PDAC Late Ablation Control 29.75
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 110.818
GSM1276603PDAC Late Ablation 214.428
GSM1276604PDAC Late Ablation 39.313
GSM1303940PDAC Late Ablation_anti-CTLA4 117.436
GSM1303941PDAC Late Ablation_anti-CTLA4 214.730
GSM1303942PDAC Late Ablation_anti-CTLA4 33357